YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Syncom Formula
Syncom Formula
BSE: 524470NSE: ISIN: INE312C01025

5th-Aug-2020 10:57Source: BSE

Syncom Formulations - Board Meeting Intimation for Holding 2/2020-21 Board Meeting For Consideration And Approval Of The Standalone Un-Audited Quarterly Financial Results For The Quarter Ended 30Th June, 2020

SYNCOM FORMULATIONS (INDIA) LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2020 ,inter alia, to consider and approve 1. Approval of the Standalone Un-audited Quarterly Financial Results of the Company for the Quarter ended on 30th June, 2020.
2. To take on record the Limited Review Report by the Statutory Auditors for Financial Results of the company for the Quarter ended on 30th June, 2020.

More Announcements on:

3rd-Sep-2020 15:25Source: BSE

Syncom Formulations - Reg. 34 (1) Annual Report

1 2 3 4 5 Next >>